MedQuist pays $6.6M to DoJ for overbilling

  
MedQuist settles suit with DoJ for millions. Image Source: ShackNews 
The U.S. Department of Justice (DoJ) has reported that medical transcription service provider MedQuist has paid the United States $6.6 million to resolve allegations under the False Claims Act that it overbilled federal government clients.

From 1998 onward, MedQuist provided medical transcription services to several federal government clients, including the Department of Veterans Affairs (VA), the Department of Defense (DoD) and the Public Health Service (PHS), part of the Department of Health and Human Services (HHS).

The government alleged that, from approximately 1998 through 2004, the Mount Laurel, N.J.-based company “knowingly overbilled VA, DoD and PHS for medical transcription services.” The DoJ said that certain federal contracts called for MedQuist to bill according to a transcription industry billing standard, called the AAMT line, and others at issue imposed slightly different billing standards.

“The federal government relies on its contractors to provide accurate billing information and it thus will act vigorously against allegations of knowing overbilling," said Gregory G. Katsas, assistant attorney general of the DoJ’s civil division.
 
The DoJ said that the settlement resolves in whole or in part allegations made in two qui tam actions, by which the False Claims Act permits private citizens to bring lawsuits on behalf of the United States. Under the settlement, relator Christopher Foley will receive $450,000 and relator Susan Purdue will receive $144,000.

The U.S. Attorney's Office for the District of Massachusetts and the DoJ’s civil division investigated the cases with oversight from the FBI, the Office of Inspector General for the VA, the Defense Criminal Investigative Service, the U.S. Postal Inspection Service, U.S. Army Criminal Investigation Command and the Office of Inspector General for the HHS.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.